Trexquant Investment’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Trexquant Investment’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,921	Closed	-$650K	–	1750
2021 Q3	$650K	Buy	+10,921	New	+$645K	0.05%	433
2020 Q3	–	Sell	-10,778	Closed	-$678K	–	1641
2020 Q2	$678K	Buy	+10,778	New	+$593K	0.05%	549
2019 Q3	–	Sell	-19,660	Closed	-$1.15M	–	1202
2019 Q2	$1.15M	Buy	+19,660	New	+$1.02M	0.1%	284
2019 Q1	–	Sell	-6,047	Closed	-$236K	–	1418
2018 Q4	$236K	Buy	+6,047	New	+$237K	0.01%	861
2018 Q3	–	Sell	-9,313	Closed	-$406K	–	1281
2018 Q2	$406K	Buy	+9,313	New	+$400K	0.03%	603
2017 Q3	–	Sell	-17,794	Closed	-$300K	–	1113
2017 Q2	$300K	Buy	+17,794	New	+$244K	0.08%	467
2015 Q2	–	Sell	-4,703	Closed	-$205K	–	1323
2015 Q1	$205K	Buy	+4,703	New	+$219K	0.02%	927

Other funds holding ARNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Trexquant Investment's ARNA Position: Q4 2021 in Review

Trexquant Investment sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 10,921 shares — an estimated $650K sold.

Trexquant Investment first reported a position in ARNA in Q1 2015 and held it in 7 quarters. The position peaked at $1.15M in Q2 2019. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

Trexquant Investment reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
Trexquant Investment sold 10,921 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $650K.
Trexquant Investment first reported a position in Arena Pharmaceuticals Inc in Q1 2015 and held it in 7 quarters.
Trexquant Investment's Arena Pharmaceuticals Inc position peaked at $1.15M in Q2 2019.
316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Trexquant Investment's 13F filing for Q4 2021, filed 14 Feb 2022.